Evidence map›Paper›PMID 25710834›Full record

ArticleNature neuroscience2015

Beyond the hammer and the scalpel: selective circuit control for the epilepsies.

Esther Krook-Magnuson, Ivan Soltesz

Abstract read
In one paragraph

Article in Nature neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Frontiers in molecular neuroscience · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Esther Krook-MagnusonDepartment of Anatomy &Neurobiology, University of California, Irvine, Irvine, California, USA.
Ivan SolteszDepartment of Anatomy &Neurobiology, University of California, Irvine, Irvine, California, USA.

Funding

Plasticity of GABAergic Inhibition Following Head InjuryR01NS035915 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SOLTESZ, IVAN · 2002 to 2017
$2.6M
Plasticity Of GABAergic Inhibition Following Head InjuryR37NS035915 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SOLTESZ, IVAN · 2005 to 2011
$2.5M
Optogenetic hub cell control for no seizures, no side-effects temporal lobe epilepsyR01NS074702 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SOLTESZ, IVAN · 2011 to 2014
$1.2M
PLASTICITY OF GABAERGIC INHIBITION FOLLOWING HEAD INJURYR29NS035915 · NINDS · UNIVERSITY OF CALIFORNIA IRVINE · PI SOLTESZ, IVAN · 1997 to 2001
$273k
On-demand optogenetic cerebellar intervention for temporal lobe epilepsyK99NS087110 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI KROOK-MAGNUSON, ESTHER · 2014 to 2014
$90k
NINDS NIH HHS K99 NS087110NINDS NIH HHS K99NS087110NINDS NIH HHS NS35915NINDS NIH HHS NS74702NINDS NIH HHS R01 NS035915NINDS NIH HHS R01 NS074702NINDS NIH HHS R29 NS035915NINDS NIH HHS R37 NS035915
6 · The paper itself

Abstract

Current treatment options for epilepsy are inadequate, as too many patients suffer from uncontrolled seizures and from negative side effects of treatment. In addition to these clinical challenges, our scientific understanding of epilepsy is incomplete. Optogenetic and designer receptor technologies provide unprecedented and much needed specificity, allowing for spatial, temporal and cell type-selective modulation of neuronal circuits. Using such tools, it is now possible to begin to address some of the fundamental unanswered questions in epilepsy, to dissect epileptic neuronal circuits and to develop new intervention strategies. Such specificity of intervention also has the potential for direct therapeutic benefits, allowing healthy tissue and network functions to continue unaffected. In this Perspective, we discuss promising uses of these technologies for the study of seizures and epilepsy, as well as potential use of these strategies for clinical therapies.

Indexed as

OptogeneticsAnimalsAnticonvulsantsEpigenesis, GeneticEpilepsyHumansNerve NetReceptors, Cell SurfaceAnticonvulsantsReceptors, Cell Surface

Identifiers

PMID25710834
PMCPMC4340083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.